BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 23 filers reported holding BIOPHARMX CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $4,000 | -63.6% | 43,216 | -55.9% | 0.00% | -100.0% |
Q4 2018 | $11,000 | -47.6% | 98,004 | -12.7% | 0.00% | 0.0% |
Q3 2018 | $21,000 | -83.6% | 112,279 | -80.6% | 0.00% | -83.3% |
Q2 2018 | $128,000 | +29.3% | 580,070 | +35.9% | 0.01% | +20.0% |
Q1 2018 | $99,000 | +130.2% | 426,837 | +184.4% | 0.01% | +150.0% |
Q3 2017 | $43,000 | – | 150,077 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 14,096,338 | $6,752,000 | 1.70% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 58,027 | $28,000 | 0.01% |
Virtu KCG Holdings LLC | 503,418 | $241,000 | 0.01% |
Baker Brothers Advisors | 598,758 | $287,000 | 0.00% |
Moors & Cabot, Inc. | 40,000 | $19,000 | 0.00% |
FRANKLIN RESOURCES INC | 9,499,615 | $4,550,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 11,385 | $5,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 323,967 | $155,000 | 0.00% |
GUGGENHEIM CAPITAL LLC | 22,718 | $11,000 | 0.00% |
OPPENHEIMER & CO INC | 28,000 | $13,000 | 0.00% |